Will the FDA approve a psychedelic-assisted therapy for a mental disorder by 2027?
Gesundheit & MedizinOne-Off2Mon
Manifold MarketsKein KYCVerifizierte AuflösungsdatenOrdentlich kalibriertAktuelle Community-Prognose
Nein 66.4%
Nein 66.4%Prognostiker
18
Fragetyp
binary
Methodik
Play-money forecasting platform
Quellentyp
Prognose
Marktdaten
Aktualisiert vor 10 Stunden
Veraltet5. Okt. 24, 02:42 UTC2. Jan. 27, 04:59 UTC
Trends
Verwandte Märkte
Verwandte Fragen als Kontext, kein Vergleich gleichwertiger Kontrakte.
Will the FDA approve any psychedelic substance for medical use this year?
KalshiWill the FDA approve any psychedelic substance for medical use before 2028?
KalshiWill MDMA-assisted therapy for PTSD be approved by the FDA before 2030?
Manifold MarketsBy 2028 end, will there be AI-assisted therapy, where therapists visually explore a patient's thoughts/memories?
Manifold MarketsBy 2030, will the FDA approve any drug in combination with a checkpoint blockade therapy that substantially reduces immune escape?
Manifold MarketsWhen will the FDA approve Compass Pathways' COMP360 Psilocybin?
KalshiRegeln
https://www.science.org/content/article/fda-rejected-mdma-assisted-ptsd-therapy-other-psychedelics-firms-intend-avoid-fate
- Resolves YES if any currently known psychedelic substance (as of October 4th, 2024) is FDA approved for any category of mental disorder by January 1st 2027.
- The caveat is mainly to avoid the possibility that any subsequent drug development produces a treatment for a mental disorder that is later found out to have psychedelic effects.
- Possible clarification from creator (AI generated): Market will resolve as N/A if the FDA is abolished before January 1st 2027.
